-
Symbol
-
GRCE on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
1,648,791 shares
-
Security Ownership %
-
9.9%
Shares, Excluding Options vs Price
ADAR1 Capital Management GP, LLC ownership in Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share (GRCE)
17 Feb 2026 - ADAR1 Capital Management GP, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,648,791 shares of Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share (GRCE).
This represents 9.9% ownership of the company.
This is the first filing by ADAR1 Capital Management, LLC disclosing ownership of Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share (GRCE).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.